300878.SZ
Zhejiang Wecome Pharmaceutical Co., Ltd.
SZSE · Healthcare · C 制造业 · CN
CNY 31.63
−5.07%Year over year
Reported trailing growth
- Revenue
- +1.9%
- EBITDA
- —
- EBIT
- -4.9%
- EPS
- -17.3%
- Free cash flow
- +98.7%
- Operating cash flow
- +405.9%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -24.9%
- EBITDA
- -63.6%
- EBIT
- -31.1%
- Net income
- -54.2%
- EPS
- -52.4%
- Free cash flow
- +99.9%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026